Calendar

Week of Apr 13, 2026

Apr 16, 2026grant136d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — The molecular and physiologic effects of calcineurin inhibitors on WNK body b...

DK grant. $769,882. PI: Cary Ragan Boyd-Shiwarski

full page →nih reporter ↗

Apr 16, 2026grant136d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Examining the Effectiveness of School-based Health Centers (SBHCs) to Improve...

NR grant. $3,480,544. PI: Michelle Trivedi

full page →nih reporter ↗

Apr 16, 2026grant136d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Volatile Organic Compound Impacts on Immune Functions During Pregnancy: Molec...

ES grant. $795,869. PI: Sean M Harris

full page →nih reporter ↗

Apr 16, 2026grant136d agoLOUISIANA STATE UNIV HSC SHREVEPORT — The role of ZBP1 in controlling HSV-1 pathogenesis

AI grant. $660,723. PI: Hongyan Guo

full page →nih reporter ↗

Apr 16, 2026grant136d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Determinants of viral assembly and infectivity within the Ebola virus VP24 pr...

AI grant. $843,182. PI: Christopher F Basler

full page →nih reporter ↗

Apr 16, 2026grant136d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — The effects and mechanisms supporting psilocybin induced pain reliefUniversity of California San Diego

AT grant. $788,967. PI: ADAM L. Halberstadt

full page →nih reporter ↗

04/17/2026recall135d agoBreeder’s Edge, Shelter’s Choice recall: Animal & Veterinary, Food & Beverages

Canine milk replacer

full page →fda recalls ↗

Apr 17, 2026approval135d agoSODIUM ACETATE — FDA approvalSODIUM ACETATE

Sponsor: EXTROVIS. Form: SOLUTION. Route: INTRAVENOUS

full page →SODIUM ACETATE →fda approvals ↗

Apr 17, 2026approval135d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval135d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval135d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval135d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval135d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: QUAGEN. Form: SYRUP. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

Apr 17, 2026approval135d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Apr 17, 2026approval135d agoCALCIPOTRIENE — FDA approvalPrasco LLC

Sponsor: GLENMARK SPECLT. Form: CREAM. Route: TOPICAL

full page →fda approvals ↗

Apr 17, 2026approval135d agoESOMEPRAZOLE MAGNESIUM — FDA approvalesomeprazole magnesium DR

Sponsor: MARKSANS PHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →esomeprazole magnesium DR →fda approvals ↗

Apr 17, 2026approval135d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 17, 2026approval135d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 17, 2026approval135d agoTETRACYCLINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals of New York LLC

Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 17, 2026approval135d agoTETRACYCLINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals of New York LLC

Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 17, 2026drug shortage135d agoLisdexamfetamine Dimesylate Capsule shortage — AlvogenAlvogen Inc

Status: Current. Reason: not specified. Form: Capsule

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoLisdexamfetamine Dimesylate Capsule shortage — Mylan Pharmaceuticals Inc., a Viatris CompanyMylan Pharmaceuticals Inc

Status: Current. Reason: not specified. Form: Capsule

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoAmphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — AlvogenAlvogen Inc

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoDextrose Monohydrate 5% Injection shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoLisdexamfetamine Dimesylate Tablet, Chewable shortage — Sun Pharmaceutical Industries, Inc.Sun Pharmaceutical Industries Ltd

Status: Current. Reason: not specified. Form: Tablet, Chewable

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoMethylphenidate Hydrochloride Tablet, Extended Release shortage — Trigen Laboratories, LLCTrigen Laboratories Inc

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoAmino Acid Injection shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoSterile Water Irrigant shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Irrigant

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoEtomidate Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoDextrose Monohydrate 10% Injection shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoLisdexamfetamine Dimesylate Capsule shortage — Sun Pharmaceutical Industries, Inc.Sun Pharmaceutical Industries Ltd

Status: Current. Reason: not specified. Form: Capsule

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoTechnetium TC-99M Pyrophosphate Kit Injection shortage — Sun Pharmaceutical Industries, Inc.Sun Pharmaceutical Industries Ltd

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoPenicillin G Benzathine Injection shortage — Pfizer Inc.PFIZER INC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoMethylphenidate Hydrochloride Tablet, Extended Release shortage — Janssen PharmaceuticalsJanssen Therapeutics

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoMethylphenidate Hydrochloride Tablet, Extended Release shortage — Sun Pharmaceutical Industries, Inc.Sun Pharmaceutical Industries Ltd

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoDexamethasone Sodium Phosphate Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoDexmedetomidine Hydrochloride Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoRemifentanil Hydrochloride Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoDextrose Monohydrate 70% Injection shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoRocuronium Bromide Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoCromolyn Sodium Concentrate shortage — Mylan Specialty, a Viatris CompanyVitalgenics LLC

Status: Current. Reason: not specified. Form: Concentrate

full page →fda drug shortages ↗

Apr 17, 2026drug shortage135d agoRifampin Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026grant135d agoUNIVERSITY OF WASHINGTON — Mentoring patient-oriented research on point-of-care diagnostics for infectio...University of Washington

AI grant. $209,758. PI: Paul K Drain

full page →nih reporter ↗

Apr 17, 2026grant135d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Assessing multi-site feasibility of an integrated whole-body hyperthermia and...University of California San Francisco

AT grant. $601,259. PI: Ashley E. Mason

full page →nih reporter ↗

Apr 17, 2026grant135d agoUNIVERSITY OF SOUTH FLORIDA — Aligning Circuit-Directed Rehabilitation with HPA Axis for Improved TBI Recovery

NS grant. $568,920. PI: Theresa Currier Thomas

full page →nih reporter ↗

Apr 17, 2026grant135d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Disrupting the Peri-necrotic Engine of Immunosuppression in GlioblastomaNorthwestern University

CA grant. $496,357. PI: DANIEL J BRAT

full page →nih reporter ↗

Apr 17, 2026grant135d agoMASSACHUSETTS GENERAL HOSPITAL — Toolkit for Optimal Pain Management in the Emergency Department: A mind-body ...Massachusetts General Hospital

AT grant. $170,640. PI: Julia E. Hooker

full page →nih reporter ↗

Apr 17, 2026grant135d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Novel Pediatric TB Diagnostics using Host and Microbial Biomarkers

AI grant. $210,302. PI: William Evan Johnson

full page →nih reporter ↗

Apr 17, 2026grant135d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Remote Loading of Melanocortin and GLP-1 Peptides in Polymers for Treatment o...

DK grant. $231,000. PI: Roger D. Cone

full page →nih reporter ↗

Apr 17, 2026grant135d agoRESEARCH TRIANGLE INSTITUTE — Development of Neuromedin Receptor 2 antagonists as Novel Analgesics

NS grant. $230,562. PI: Thuy Nguyen

full page →nih reporter ↗

← prev

page 47 of 132

Week of Apr 13, 2026